1. Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug
    Behrouz Hassannia et al, 2020, Biochemical Pharmacology CrossRef
  2. Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: A phase I trial
    Nichelle Pires et al, 2020, Journal of Ayurveda and Integrative Medicine CrossRef
  3. Withaferin A Induces Oxidative Stress-Mediated Apoptosis and DNA Damage in Oral Cancer Cells
    Hsueh-Wei Chang et al, 2017, Frontiers in Physiology CrossRef
  4. Anti-proliferative effect of isorhamnetin on HeLa cells through inducing G2/M cell cycle arrest
    Juan Wei et al, 2018, Experimental and Therapeutic Medicine CrossRef
  5. Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression
    Shuichiro Okamoto et al, 2016, Cancer Science CrossRef
  6. Withaferin-A—A Natural Anticancer Agent with Pleitropic Mechanisms of Action
    In-Chul Lee et al, 2016, International Journal of Molecular Sciences CrossRef
  7. Withaferin a Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress
    Tsu-Ming Chien et al, 2021, Antioxidants CrossRef
  8. Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal
    Suneel Kumar et al, 2023, Pharmaceuticals CrossRef
  9. Anti-proliferation of triple-negative breast cancer cells with physagulide P: ROS/JNK signaling pathway induces apoptosis and autophagic cell death
    Pei Yu et al, 2017, Oncotarget CrossRef
  10. Withania somnifera Has Potential to Treat Cancer
    Babli Halder et al, 2017, Science of Ashwagandha: Preventive and Therapeutic Potentials CrossRef
  11. Pharmacological Targeting of Ferroptosis in Cancer Treatment
    Amaneh Mohammadi Roushandeh et al, 2022, Current Cancer Drug Targets CrossRef
  12. α-Lipoic Acid-Plus Ameliorates Endothelial Injury by Inhibiting the Apoptosis Pathway Mediated by Intralysosomal Cathepsins in an In Vivo and In Vitro Endothelial Injury Model
    Yang Wang et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  13. Attenuating role of withaferin A in the proliferation and migration of lung cancer cells via a p53‑miR‑27a/miR‑10b pathway
    Chen-Chu Lin et al, 2021, Oncology Letters CrossRef
  14. Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics
    Vivek K. Kashyap et al, 2022, Pharmaceutics CrossRef
  15. Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
    Yue Yu et al, 2017, Cell Death & Disease CrossRef
  16. The Potential Pharmacological Effects of Natural Product Withaferin A in Cancer: Opportunities and Challenges for Clinical Translation
    Geetanjali Devabattula et al, 2024, Planta Medica CrossRef
  17. Nimbolide Represses the Proliferation, Migration, and Invasion of Bladder Carcinoma Cells via Chk2-Mediated G2/M Phase Cell Cycle Arrest, Altered Signaling Pathways, and Reduced Transcription Factors-Associated MMP-9 Expression
    Seung-Shick Shin et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
  18. Scientific Validation of the Usefulness of Withania somnifera Dunal in the Prevention and Treatment of Cancer
    G. S. Pavan Kumar Achar et al, 2018, Anticancer plants: Properties and Application CrossRef
  19. Mechanisms of Anti-Tumor Activity of Withania somnifera (Ashwagandha)
    Vikrant Mehta et al, 2021, Nutrition and Cancer CrossRef
  20. Molecular insights into cancer therapeutic effects of the dietary medicinal phytochemical withaferin A
    Chandra Sekhar Chirumamilla et al, 2017, Proceedings of the Nutrition Society CrossRef
  21. Analytical Strategies to Investigate Molecular Signaling, Proteomics, Extraction and Quantification of Withanolides – A Comprehensive Review
    Sinchana B Gopalaiah et al, 2024, Critical Reviews in Analytical Chemistry CrossRef
  22. Withaferin-A as a Potential Candidate for Cancer Therapy: Experimental Evidence of Its Effects on Telomerase Plus and Minus Cancer Cells
    Zeenia Kaul et al, 2017, Science of Ashwagandha: Preventive and Therapeutic Potentials CrossRef
  23. Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer
    Akash Saggam et al, 2020, Journal of Ethnopharmacology CrossRef
  24. Synthesis, characterization, antitumor potential, and investigation of mechanism of action of copper(ii) complexes with acylpyruvates as ligands: interactions with biomolecules and kinetic study
    Nenad Joksimović et al, 2022, RSC Advances CrossRef
  25. Prenatal epigenetics diets play protective roles against environmental pollution
    Shizhao Li et al, 2019, Clinical Epigenetics CrossRef
  26. Withanolides: Promising candidates for cancer therapy
    Qiang Zhang et al, 2024, Phytotherapy Research CrossRef
  27. 3′-hydroxy-3,4,5,4′-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model
    Hanna Piotrowska-Kempisty et al, 2016, Scientific Reports CrossRef
  28. In vitro shoot multiplication using meta-Topolin and leaf-based regeneration of a withaferin A rich accession of Withania somnifera (L.) Dunal
    Kuldeep Kaur et al, 2021, Industrial Crops and Products CrossRef
  29. Molecular targets and mechanisms of anti-cancer effects of withanolides
    Zhiruo Zhang et al, 2023, Chemico-Biological Interactions CrossRef
  30. Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4‐ATF3‐CHOP axis
    Qin Tang et al, 2020, Cell Proliferation CrossRef